Page 25 - Marc Casper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thermo Fisher buys PPD for $17.4b in Waltham giant’s largest deal to date By Anissa Gardizy and Jonathan Saltzman Globe Staff,Updated April 15, 2021, 12:40 p.m. Email to a Friend Thermo Fisher’s share price rose more than 3.4 percent Thursday, closing at $494.38.Thermo Fisher Thermo Fisher Scientific, the Waltham laboratory equipment maker with the biggest market value of any Massachusetts company, said Thursday that it’s paying $17.4 billion for a North Carolina company that helps drug makers run clinical trials. The cash deal to acquire PPD marks the latest merger involving c...

MichaelVi - stock.adobe.com The Waltham, MA-based company is set to acquire a PPD for $17.4 billion. Thermo Fisher Scientific’s acquisition follows a string of high-value deals that have recently occurred in the industry. Thermo Fisher Scientific is making a multi-billion-dollar acquisition that will enhance its position in the biotech industry. The Waltham, MA-based company announced it will acquire PPD, a provider of clinical research services to the pharma and biotech industry, for $47.50 a share or $17.4 billion-plus the assumption of about $3.5 billion of net...

Thermo Fisher Buys PPD for $17.4B, as Healthcare Deals Soar Related Stories April 8, 2021 April 1, 2021 April 1, 2021 Thermo Fisher Scientific Inc. has agreed to acquire PPD Inc., a provider of clinical and research services to the pharma and biotech industries, for $17.4 billion as healthcare deal making soars amid the pandemic. Thermo Fisher will pay $47.50 a share for PPD, according to a statement Thursday, and will assume about $3.5 billion of net debt. The price represents a premium of about 24% to the PPD closing price Tuesday, before reports of a possible deal. Companies like PPD that...

By Reuters Staff 2 Min Read (Reuters) - Medical device maker Thermo Fisher Scientific Inc said on Thursday it would acquire contract researcher PPD Inc for $17.4 billion as it adds more muscle to its pharmaceutical services business. Thermo Fisher, the world’s largest maker of scientific instruments, will pay $47.50 per share - a premium of 10.6% to PPD’s Wednesday closing price. Over the past few years, Thermo Fisher has doubled down on boosting its business of supplying raw materials used to make treatments and signed several deals. It bought Brammer Bio, a viral vector manufacturer for...

Carl O’Donnell, Dania Nadeem 2 分钟阅读 (Adds company comments from call, background, share movement) Feb 1 (Reuters) - Thermo Fisher Scientific Inc on Monday forecast 2021 profit above market estimates and posted better-than-expected quarterly earnings as it continues to gain from upbeat demand for its COVID-19 tests and materials for vaccine production. Thermo Fisher has been one of the major providers of COVID-19 tests to governments and healthcare providers during the pandemic and also manufactures some of the raw materials used to make vaccines against the novel coronavirus. Earlie...